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Abstract
Both human herpes viruses and Chlamydia are highly prevalent in the human population and are detected together in
different human disorders. Here, we demonstrate that co-infection with human herpes virus 6 (HHV6) interferes with the
developmental cycle of C. trachomatis and induces persistence. Induction of chlamydial persistence by HHV6 is independent
of productive virus infection, but requires the interaction and uptake of the virus by the host cell. On the other hand, viral
uptake is strongly promoted under co-infection conditions. Host cell glutathione reductase activity was suppressed by
HHV6 causing NADPH accumulation, decreased formation of reduced glutathione and increased oxidative stress. Prevention
of oxidative stress restored infectivity of Chlamydia after HHV6-induced persistence. We show that co-infection with Herpes
simplex virus 1 or human Cytomegalovirus also induces chlamydial persistence by a similar mechanism suggesting that
Chlamydia -human herpes virus co-infections are evolutionary shaped interactions with a thus far unrecognized broad
significance.
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Introduction
The Gram-negative, obligate intracellular bacterium Chlamydia
trachomatis is the leading infectious cause of blindness and the
third most frequent sexually transmitted infection worldwide.
Chlamydia (Chlamydophila) pneumoniae, a highly prevalent pathogen
with up to 80% serum positivity in adults, is the cause of
pneumonia in humans, but has also been associated with
chronic diseases like atherosclerosis, progressive neurological
disorders and lung cancer [1,2,3]. Chlamydia has a biphasic
developmental cycle with infectious but metabolically inert
elementary bodies (EB), which differentiate into larger, meta-
bolically active non-infectious reticulate bodies (RB). At the end
of the life cycle, RB re-differentiates into infectious EB to start a
new round of infection. Chlamydia enters into a persistent phase
when exposed to adverse physiological conditions (e.g. amino
acid starvation, iron deficiency), and if treated with antibiotics
or interferon-c (IFN-c) [4]. This phase is characterized by
bacterial genome replication without bacterial division or
production of infectious bacteria, leading to formation of
enlarged so called aberrant bodies [5]. Also co-infection with
Herpes simplex virus 1 and -2 (HSV-1, -2) induces persistence
of C. trachomatis [6,7,8,9]. So far, mechanisms underlying virus-
mediated persistence have not been defined.
Human herpes virus 6 (HHV6) belongs to the b-herpesvirus
family and is a ubiquitous pathogen showing more than 90%
serum positivity in healthy adults. It has CD4+ T-lymphocyte
specificity but has been shown to infect many different cell types
in vitro [10]. Usually asymptomatic, HHV6 is associated with the
common, self-limited childhood illness roseola infantum, and
rarely with more severe syndromes. In immune compromised
patients, reactivation of viral activity may lead to severe limbic
encephalitis. There are two subtypes of HHV6, HHV6A and
HHV6B with similar infection characteristics but different tissue
tropism [10]. The virus persists either in a lytic or latent phase
inside the host cell.
Epidemiological studies have connected HHVs and Chlamydia
in several in vivo conditions. HSV2 is associated with C.
trachomatis in endometritis and acute salpingitis [11]. HHV6 has
long been one of the most probable candidates for the
development of autoimmune disorders like multiple sclerosis
(MS). Co-infection of C. pneumoniae is observed in MS [12] and
in chronic fatigue syndrome (CFS) patients [13].
Here, we studied the survival and infectivity of C. trachomatis and
HHV6 in a co-infection model. Our data suggests that HHV6
infection modulates cellular glutathione reductase (GSR) activity
leading to increased oxidative stress and decreased levels of
reduced glutathione (GSH). We show that these conditions induce
chlamydial persistence providing the first mechanistic insight into
how herpes virus co-infections affect the infectivity of Chlamydia.
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Results
HHV6 Induces Persistence of Chlamydia trachomatis in
Epithelial Cells
To investigate the possible interaction between HHV6 and
Chlamydia during in vitro co-infections, we infected HeLa cells
simultaneously with either HHV6 strain U1102 (HHV6A) or Z29
(HHV6B) at 5–10 infectious units per cell and C. trachomatis LGV
L2 at a multiplicity of infection (MOI) of 1. After 24 h of infection,
electron microscopic analysis revealed formation of aberrant
inclusions in co-infected cells, which were absent in single
Chlamydia-infected cells (Figure 1A, B). While normal bacterial
inclusions contained EBs and RBs, morphologically altered
inclusions of co-infected cells were filled with large so-called
aberrant bodies reminiscent of persistent Chlamydia (Figure 1A,B).
Chlamydial persistence has been shown to coincide with reduced
bacterial infectivity [14]. We therefore infected HeLa cells for 48 h
and used the lysates to re-infect fresh cells (secondary infection
assay or infectivity assay). Secondary infections under standard
conditions yielded more than 3.56106 inclusion forming units in
56105 cells. In contrast, no inclusions were formed when lysates
from co-infected cells were used, indicating a complete loss of
infectivity (Figure 1C). Such a dramatic loss of infectivity was not
observed in co-infections with other members of the order
Chlamydiales. HHV6 co-infection with C. pneumoniae or Simkania
negevensis (SN) induced no obvious, aberrant inclusions of primary
infected cells (data not shown). But, infectivity was reduced by
36.4% and 59.1% in co-infections with C. pneumoniae and HHV6A
or 6B, respectively, and 15.0% in co-infections of SN and HHV6A
(Figure S1A,B), showing that HHV6’s influence on the Chlamydiales
infectivity differs during co-infection.
To further characterize the onset of persistence during co-
infection, HHV6 was added at different time points to Chlamydia-
infected cells and infectivity was determined. Loss of infectivity or
strongly reduced infectivity was observed if the virus was added up
to 16 h after infection with C. trachomatis. While addition of the
virus at 20 h post infection (p.i.) and 24 h p.i. resulted in 20% and
12% loss of infectivity, respectively, no obvious effect was observed
when the virus was added at later time points (Figure 1D, S1C).
Interestingly, loss of infectivity caused by co-infection with HHV6
was reversible since removal of the virus from the supernatants as
late as 26 to 30 h p.i. restored infectivity (Figure 1D, S1C). These
data demonstrated that presence of HHV6 in the early phase of
the developmental cycle drives Chlamydia into a non-infectious
phase.
HHV6 is a lymphotrophic virus [15] and C. trachomatis L2 causes
lymphogranuloma venerum and has been demonstrated to grow
in lymphocytes and macrophages [16], One of the most possible
sites for in vivo co-infection are therefore human blood cells
including macrophages and T-cells. Hence, we first tested the co-
infection in T-cell derived HSB2 cells, which allows productive
HHV6A infection. We observed similar persistent chlamydial
infections in these cells when co-infected with HHV6A (Figure 1E).
We then isolated peripheral blood mononuclear cells (PBMCs)
from 5 healthy individuals and used them for infection either with
C. trachomatis alone or together with HHV6A. Monocyte derived
macrophages were separated in all these samples and were
infected separately (see Material and Methods). We observed
mostly persistent chlamydial infection in majority of the infected
macrophages (Figure 1E) in presence of HHV6A co-infection,
whereas macrophages allowed productive chlamydial infection in
the absence of HHV6A (Figure 1E). In freshly isolated PBMCs,
chlamydial infection was predominant in macrophages with very
few other cell types also showing chlamydial infection. It is
noteworthy that the aberrant RBs in persistent chlamydial
inclusions were comparatively smaller in size in monocyte-derived
macrophages than in cultured epithelial cells. We performed
chlamydial infectivity assay in macrophages, which confirmed the
visual observations of chlamydial persistence in the presence of
HHV6A (Figure 1F). As chlamydial infection is inefficient and
asynchronous in suspension cells, we could not perform infectivity
assay in the rest of the leukocytes separated from PBMCs. Thus
these data supports our hypothesis that human blood cells,
especially macrophages and T cells, can allow natural co-infections
thus leading to persistent chlamydial life cycle.
Virus-induced Persistence is Independent of Interferon
(IFN) and Allows Long-term Chlamydial Replication
Microarray expression profiling of various IFNs, under different
infection conditions was used to rule out host cell anti-viral
responses, which may influence chlamydial survival and infectivity.
mRNA expression pattern of various IFNs between single
Chlamydia infections and co-infections remained unaltered (Figure
S2A). We could also exclude any soluble factor from the HHV6
producing cell line HSB2/Molt-3, since only cell supernatants
harvested before virus release (around 4–5 days post HHV6
infection) did not induce chlamydial persistence (data not shown).
Further, supernatants from HSB2/Molt-3 prepared after remov-
ing the virus by centrifugation or precipitation failed to induce
chlamydial persistence (data not shown). We nevertheless used
HHV6 stocks purified by ultra-centrifugation for all further co-
infection experiment to avoid any possible contamination from the
virus stock.
We then compared genome replication patterns of C. trachomatis
induced to persistence either by HHV6 co-infection or antibiotics
treatment. In general, bacterial replication was higher in HHV6A
than HHV6B co-infection (Figure 2A,B), as was measured by
quantitative real time PCR (qPCR) of the chlamydial type III
secretion chaperone LcrH/SycD. In the presence of penicillin G, a
well-known inducer of chlamydial persistence [17], replication of
chlamydial DNA stopped at 3–4 days p.i. Chlamydial genome
replication continued until day 9 p.i. in both, HHV6A/B co-
infections (Figure 2A,B), indicating a continuous replication of
chlamydial DNA irrespective of the complete loss of infectivity.
Chlamydial Persistence Requires Interaction of Viral
Particles with Host Cells
To understand the effect of viral activity on bacterial
persistence, co-infection experiments with UV-inactivated
HHV6A/B strains were performed. The inactivation efficiency
was verified by testing the ability of these viruses to initiate
productive infection in HSB2 or Molt-3 cells (data not shown).
Interestingly, as previously observed during HSV2 co-infection
[8], chlamydial persistence was induced with both HHV6 strains
after UV inactivation (Figure 1C). This could be explained by the
viral capability to enter into the host cell in spite of UV treatment,
as we still detected low levels of viral immediate early (IE) gene
U94 transcription in HeLa cells infected with UV-inactivated virus
(data not shown). We then created HeLa cell lines harboring latent
HHV6A or HHV6B DNA by repeated infection of these cells with
HHV6A or 26B (see Material and Methods S1, Figure S2B) over
a time period of several weeks after which these cells carried 50–
100 copies of viral DNA per 1000 cells (data not shown). In
addition to this, viral latency was characterized by high expression
of latency specific U94 transcripts (Figure S2B) in the absence of
any other viral transcripts [18,19]. Interestingly, chlamydial
persistence was not observed in cells latently infected with
HHV6 Co-Infection Induces Chlamydial Persistence
PLOS ONE | www.plosone.org 2 October 2012 | Volume 7 | Issue 10 | e47427
HHV6 Co-Infection Induces Chlamydial Persistence
PLOS ONE | www.plosone.org 3 October 2012 | Volume 7 | Issue 10 | e47427
HHV6A/B strains (Figure 1B,C). Three additional T cell lines
containing chromosomally integrated HHV6A (CiHHV6A) (1–2
copies per cell) were infected with Chlamydia and were studied for
bacterial persistence by transmission electron microscopy (TEM).
No persistent inclusions were observed in these cells even after
48 h p.i. (data not shown). Infectivity could not be quantified in
these cells since corresponding control cell lines lacking latent
HHV6A were not available. Thus our data suggests that direct
interaction of HHV6 with host cells is required to induce
chlamydial persistence. To check this possibility, CHO cells,
which are not susceptible to HHV6A/B, were co-infected and
chlamydial infectivity was tested. Neither HHV6A nor HHV6B
mediated chlamydial persistence in CHO cells (Figure 2C,D). In
line with these findings, RNAi-mediated silencing of CD46, a
receptor for entry of HHV6A, but not HHV6B [20], prevented
HHV6A, but not HHV6B-mediated chlamydial persistence
(Figure 2E,F), supporting the notion that entry of HHV6 is
essential for inducing chlamydial persistence during co-infection.
Induction of Persistence is Independent of Productive
Virus Infection
HeLa cells are not productively infected by HHV6 as infected
cells cannot produce viral glycoproteins or intact viral particles.
Since induction of persistence of Chlamydia depended on the
continuous presence of the virus in HeLa cells, we asked, if these
restrictions also exist in primary cells susceptible to HHV6
infection. Human umbilical vein endothelial cells (HUVEC) serve
as a natural reservoir for HHV6 allowing active viral particles to
survive for prolonged time without productive viral infection
[21,22]. Most HUVEC cells primarily infected with HHV6A
expressed viral proteins like gp116 and p41 by 72 hours p.i.
(Figure S2C) which then decreased over time. However, viral
DNA and proteins were detectable even 3 weeks after virus
infection. When these HUVEC cells after 7–8 passages were
infected with Chlamydia, the development of chlamydial infectious
EB was still inhibited (Figure 2G,H). Thus, in susceptible cells,
HHV6 infection induces Chlamydia persistence even in the absence
of active viral infection.
Chlamydia Infection Favors HHV6 Entry and Survival
The fact that chlamydial infectivity is also affected in cells
susceptible to HHV6 infection suggested that induction of
persistence rather requires viral products inside a cell than the
interaction of the virus with cell surface receptors. We therefore
tested the influence of Chlamydia infection on viral entry and
survival in HeLa cells. Under single infection conditions, HeLa
cells do not allow HHV6 survival and replication (Figure 3A).
Interestingly, the amount of HHV6 DNA increased dramatically
during an active co-infection with Chlamydia (Figure 3A, 3B). To
ascertain whether the increase in viral DNA results from increased
viral entry or replication, we removed the virus containing media
2 h p.i. and washed the co-infected cells thoroughly. This
decreased the amount of viral DNA and was comparable to
single infections (Figure 3C). Hence, the increase in viral DNA was
a result of increased viral uptake rather than viral replication. On
the contrary, Chlamydia replication was down regulated when co-
infected with HHV6 (Figure S3A). We then examined the
dependency of increased viral uptake to the presence of active
chlamydial growth. For this, we added either Penicillin G or
Doxycycline to infected cells at 24 h p.i., which resulted in gradual
chlamydial death and/or removal and studied the viral and
bacterial DNA amount over a time period of 9 days. Antibiotics
treatment did not affect single viral infection (Figure S3B) but
strongly reduced the presence of both bacterial and viral DNA in
co-infections (Figure 3D,E), suggesting that Chlamydia infection
significantly supports the entry of HHV6 in non-susceptible cells.
Further, not only viral entry was increased, but also the viral
early transcription machinery appeared strongly activated. We
compared the viral DNA amount to viral IE gene U94
transcription during HHV6A single infection and co-infection.
The viral DNA was 2.5 fold higher after 24 h post infection
(Figure 3F), whereas U94 RNA transcript was 55 fold higher
under similar infection conditions thus indicating a strong increase
in viral transcription. In another set up, transcription of HHV6A
and -6B U94 was compared to that of UV-inactivated viruses
(Figure 3G,H). Transcription of U94 was dependent on intact
viruses since co-infections with UV-inactivated HHV6A and 6B
did not result in any major change in U94 transcription
(Figure 3G,H). The increase in viral activity was also confirmed
by the increased transcription of other IE genes (U42), early genes
(U79) and late genes (U22) (Figure S3C). These results suggest that
Chlamydia infection aids rapid viral uptake and survival inside the
host cell accompanied by effective viral gene transcription.
Co-infection Induces Severe Oxidative Stress
Chlamydia growth is directly dependent on host cell ATP levels
since they have reduced metabolic activity and depend on the
uptake of host nucleotides [23]. Hence, we investigated the
integrity of the mitochondria as one source of host cell ATP. We
observed a substantial decrease in mitochondrial membrane
potential in co-infected HUVEC (Figure 4A) and HeLa cells
(Figure S4A). Loss of mitochondrial membrane potential may be
the cause or consequence of reactive oxygen species (ROS) [24,25]
that are rapidly converted to H2O2 by superoxide dismutases
(SODs) in the cell. We therefore tested whether infected cells have
Figure 1. Co-infection of HHV6 induces persistence of C. trachomatis. (A) Morphology of Chlamydia. Transmission electron microscopy (TEM)
images of chlamydial inclusions. (a) Single Chlamydia infection, (b) co-infection with HHV6A. (B) Chlamydial inclusions of co-infected cells differ in
morphology compared to single infected cells. Chlamydia was stained with an antibody against cHsp60 (red) and the host cell nuclei were visualized
by Draq5 staining (blue). In the upper panel, cells were additionally transfected with Golgi-GFP fusion protein constructs. Samples were viewed under
a confocal laser microscopy. (C) Co-infection with HHV6A and -6B induces chlamydial persistence. HeLa cells were infected with C. trachomatis (Ctr)
alone or together with either HHV-6A, -6B, UV inactivated HHV6A (UV.HHV6A) or -HHV6B (UV.HHV6B). In parallel, latent HHV6 (lat.HHV6A and
lat.HHV6B) containing HeLa cells were infected with Ctr. The bars indicate inclusion-forming units (IFU) obtained after standard infectivity assays as
described in Materials and Methods. Data represent the mean6 SEM of three independent infection experiments. (D) Early co-infection with HHV6 is
necessary for inducing chlamydial persistence. HeLa cells were infected with Chlamydia for 2 h prior to the addition of viral particles for different time
points as indicated. In a parallel infection set up, HHV6A was added to Chlamydia-infected cells after 2 h, but subsequently HHV6 was removed from
the infection media at the indicated time points. Infectivity assays were performed as described in materials and methods. NI: no infection. Data
represent the mean6 SEM of three independent infection experiments. (E) TEM images of chlamydial inclusions in HSB2 cells (a, b) and in monocyte-
derived macrophages from healthy blood donors (c, d). Cells were either infected with Ctr alone (a, c) or together with HHV6A (b, d). (F) Chlamydial
infectivity is down regulated in monocyte-derived macrophages in presence of HHV6A co-infection. Freshly isolated macrophages were infected with
C. trachomatis (Ctr) alone or together with HHV6A and chlamydial infectivity was determined. Data represent the mean 6 SEM of three independent
samples.
doi:10.1371/journal.pone.0047427.g001
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Figure 2. HHV6-mediated chlamydial persistence differs from other forms of chlamydial persistence and depends on viral entry.
(A,B) HHV6-mediated chlamydial persistence differs from that induced by Penicillin G. HeLa cells were co-infected with Chlamydia and HHV6A (A) or
HHV6 Co-Infection Induces Chlamydial Persistence
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elevated levels of ROS. In line with recently published data [26],
Chlamydia infection caused elevated cellular ROS levels at early
time points of infection, which decreased to control levels within
24 h of infection (Figure 4B). Co-infected cells showed a similar
trend but ROS level remained significantly higher at any time
when compared to single Chlamydia infection. HHV6 infection
induced ROS right from the start of infection and ROS level
remained high throughout 48 h of infection (Figure 4B). It is well
established that ROS, under normoxic conditions, induces the
stabilization of hypoxia-inducible factor 1 alpha (Hif-1alpha)
[27,28], a major transcription factor controlling the physiology
and survival of tumor cells. We have recently demonstrated that
Hif-1alpha is stabilized in cells infected with C. trachomatis and
induces the strong up-regulation of the tumor suppressor and
apoptosis inhibitor Mcl-1 [29]. Interestingly, co-infection caused a
shift in the up-regulation of Hif-1alpha to early time points (4–8 h)
and a strongly increased overall expression at later time points
(24 h and 32 h) (Figure 4C, S4B, S5). Further, Hif-1alpha was
found in the nucleus (Figure S5) and Mcl-1 was highly up-
regulated in co-infected cells (Figure S4B), indicative of a full
activation of its transcriptional activity. It is well known, that
NADPH oxidases are a major source of cellular ROS production
[30]. Nox1 is over expressed in many epithelial cell lines and has
been linked to mitochondrial ROS generation in response to
different stimuli including IFNc [31]. We therefore tested the
involvement of NOX1 in co-infection induced deregulation of
ROS production. We silenced the expression of NOX1 (Figure 4D)
and tested the effect on chlamydial persistence induced by co-
infection. Silencing of NOX1 reduced the co-infection induced
production of ROS by 40% (Figure 4E) and rescued chlamydial
infectivity to 33% (Figure 4F,G). These results indicated a role of
NOX1 induced ROS production for the persistence induced by
co-infection.
GSH Levels are Critical to Maintain Chlamydial Infectivity
Glutathione peroxidase plays a major role in the detoxification
of H2O2. Reduced glutathione (GSH), a strong antioxidant and
free radical scavenger is required for the activity of glutathione
peroxidase. Hence, we measured intracellular GSH under
different infection conditions over an infection period of 32 h.
Interestingly, GSH levels dropped during the early phase of
Chlamydia growth in single infected compared to non-infected cells
but then strongly increased at 12 h p.i. and remained at the level
of control cells (Figure 5A). In contrast, GSH level in HHV6A
infected as well as co-infected cells were low throughout the time
period (Figure 5A), suggesting that the virus counteracts the
increase in GSH seen with Chlamydia infected cells.
To test the hypothesis, that an imbalance in reduced glutathione
(GSH)/oxidized glutathione (GSSG) in the co-infected cell drives
Chlamydia to persistence, we used reducing agents known to reduce
GSSG to GSH. Addition of N-acetyl cysteine (NAC) to co-infected
cells indeed increased the GSH levels (Figure 5B). Interestingly,
addition of NAC (Figure 5B) partially and of the strong reducing
agent Dithiothreitol (DTT) (Figure 5C) completely reverted the
persistence of Chlamydia in co-infected cells without preventing
viral entry (Figure S6A). Furthermore, DTT prevented the early
induction of Hif-1alpha and Mcl-1 (Figure S4B), demonstrating a
role of oxidative stress in the activation of these important
regulators of cell physiology and survival.
In line with these findings, depletion of ROS by the addition of
SOD also rescued the chlamydial infectivity (Figure S6B, S6C),
demonstrating a general role of oxidative stress in the loss of
chlamydial infectivity in co-infections with HHV6. However, in
line with an initial increase in ROS (Figure 4B), ROS are required
in the early phase of chlamydial infection, since pre-incubation of
the cells with SOD completely prevented primary infection (Figure
S6B,C).
To test whether interference with the cellular glutathione system
is sufficient to cause loss of chlamydial infectivity, we made use of
buthionine sulfoximine (BSO), an inhibitor of c-glutamylcysteine
synthetase, which prevents cellular glutathione synthesis. BSO
treatment induced a dose-dependent loss of infectivity, but had no
effect on the primary infection of Chlamydia in the absence of virus
infection (Figure 5B), supporting a role of the cellular glutathione
system for the development of infectious Chlamydia.
Glutathione Reductase is a Target of Co-infection
Induced Chlamydial Persistence
Glutathione reductase (GSR) is the central enzyme that reduces
GSSG to GSH. We therefore tested whether interfering with GSR
activity could mimic HHV6 infection in inducing chlamydial
persistence. Inhibition of GSR activity with 2-acetylamino-3-[4-(2-
acetylamino-2-carboxyethylsulfanylthiocarbonyl-amino)phe-
nylthio-carbamoylsulfanyl] propionic acid (2-AAPA) (Figure S6D)
induced loss of chlamydial infectivity (Figure 5D). RNAi-induced
silencing of host cell GSR (Figure S6E) caused an increase in ROS
(Figure 5E) and significantly reduced the formation of infectious
Chlamydia (Figure 5F, S6F), demonstrating a potential role of GSR
for the virus-induced chlamydial persistence.
GSR depends on NADPH as co-enzyme and donor for
electrons for the reduction of GSSG to GSH. We therefore
measured NADPH levels in infected and co-infected cells, since it
is an indicator of the enzyme activity [32]. Surprisingly, NADPH
levels were not measurable in Chlamydia-infected cells (Figure 6A),
suggesting that NADPH is fully consumed in infected cells. Low
HHV6B (B) for different time intervals in the absence (-PenG) or presence of 10 U/ml of Penicillin G (+PenG). Chlamydial DNA was quantified by qPCR
using a primer set against chlamydial ORF LcrH/SycD and normalization against 5S rDNA. Data represent the mean 6 SEM of three independent
infection experiments. (C,D) CHO cells do not permit HHV6-mediated chlamydial persistence. Infectivity assays were performed in CHO cells using
both HHV6A and HHV6B and analyzed by Western blot (C) or inclusion counting after staining the chlamydial inclusions with an antibody against
cHsp60 and Cy2-labeled secondary antibody (D). Statistical analysis was based on the Student t-test, and p.0.05 was considered as insignificant. IFU,
inclusion forming units. (E,F) Silencing of CD46 prevents HHV6A-mediated chlamydial persistence, but not that of HHV6B. Human CD46 was silenced
by transfection of siRNAs in HeLa cells and the knock down efficiency was checked with an antibody against human CD46. Infectivity assays were
performed and analyzed by Western blot (E) or inclusion counting (F) after staining the chlamydial inclusions with an antibody against cHsp60 and
Cy2 labeled secondary antibody. Statistical analysis was based on the Student t-test, and p.0.05 was considered as insignificant whereas p,0.05 was
considered as significant. IFU/ml in figure (D) and (F) represent the mean 6 SEM of three independent infection experiments. (G) Productive and
latent HHV6 infection affects chlamydial replication in HUVEC cells. C. trachomatis (Ctr) and HHV6A were used to infect either HUVEC cells, which were
or were not pre-infected with HHV6A for 2–3 weeks (latH6A) as indicated. DNA was extracted and used for amplifying bacterial DNA as described
under (A). Data represent the mean of 3 independent experiments. hpi, hours post infection; dpi, days post infection. (H) Productive HHV6 infection
induces chlamydial persistence. Chlamydial infectivity assays were performed and evaluated by detecting chlamydial Hsp60 (cHsp60) by
immunoblotting. Fold change values indicate the ratio of cHsp60 to actin values obtained after signal quantification using densitometric analysis. PI,
primary infection; SI, secondary infection. NI: no infection.
doi:10.1371/journal.pone.0047427.g002
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NADPH levels are in line with high levels of GSH and active
detoxification of ROS (Figure 4B, 5A). Increased NADPH
concentrations compared to control cells were measured in cells
infected with HHV6A or HHV6B, whereas NADPH levels were
Figure 3. Co-infection of HHV6 and C. trachomatis (Ctr) favors viral entry and survival. (A) HeLa cells were infected with HHV6A for
different time intervals either in presence or absence of Ctr. Viral DNA was quantified by qPCR, using a primer set against viral the U94 gene. (B) The
amount of HHV6A and Chlamydia (Ctr) DNA increases during co-infection. HeLa cells were co-infected with HHV6A and Ctr for different time intervals.
DNA was extracted and used for qPCR with primers for viral U94 ORF and chlamydial LcrH/SycD. Relative DNA amount values are presented in log
scale. (C) Removal of virus particles from the supernatant during co-infection prevents the increase of viral DNA. HeLa cells were infected with HHV6A
either in presence or absence of Ctr. Two hours post infection (hpi), cells were washed and fresh culture medium was added. Viral DNA was quantified
at different time points by qPCR, using a primer set against viral U94 gene. Data represent the mean of 3 independent experiments. (D,E) Inhibition
of Chlamydia growth with 10 U/ml Penicillin G (B) or 100 ng/ml doxycyclin (C) reduces viral DNA amount. Antibiotics were added to the co-infected
cells at 24 h p.i. Data represent the mean of 3 independent experiments. Relative DNA amount values are presented in log scale. hpi, hours post
infection; dpi, days post infection. (F) Viral U94 transcription is induced during co-infection. HeLa cells were co-infected in duplicates with HHV6A and
Chlamydia (Ctr) for 24 h. Total DNA and RNA was extracted and viral U94 DNA and RNA transcript levels were quantified by qRT-PCR and normalized
against 5S rDNA or 5S rRNA respectively. **, p# 0.005. (G,H) HHV6A (G) or HHV6B (H) U94 transcription is increased during co-infection. HeLa cells
were co-infected with HHV6A, UV-inactivated HHV6A (UV.HHV6A) and Chlamydia (Ctr) for 24 h as indicated. Total RNA was extracted and viral U94
transcript levels were quantified by qRT-PCR and normalized against 5S rRNA. hpi, hours post infection; dpi, days post infection. *, p# 0.05; **, p#
0.005. All the data represent the mean of 3 independent experiments performed on the same day.
doi:10.1371/journal.pone.0047427.g003
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Figure 4. HHV6 co-infection induces mitochondrial membrane potential loss and reactive oxygen species (ROS) formation. (A) Co-
infection of HHV6 and Ctr down regulates mitochondrial membrane potential in HUVEC cells. HUVEC cells were infected with Ctr and/or HHV6A.
Mitochondrial membrane potential was visualized by staining with MitoTracker (red) and fluorescence microscopy. (B) HHV6 infection increases ROS
in host cells. HeLa cells were infected with Chlamydia (Ctr), HHV6A or both for three different time intervals. At the end of the infection, cell-
permeable fluorogenic probe 29, 79-Dichlorodihydrofluorescin diacetate (DCFH-DA) was added for 1 h at 37uC. Total cellular ROS content was
measured using an Elisa reader. Data represent the mean 6 SEM of three independent infection experiments performed at the same day. Statistical
analysis was based on the Student t-test, and p values between different sample groups are mentioned above the respective line bars. (C) HHV6A
and -6B induces Hif-1alpha expression. HeLa cells were infected with Ctr and/or HHV6A or -6B for different time intervals and Chlamydia (cHSP60) and
Hif-1a were detected by immunoblotting. Actin was used as a loading control. Fold change values of Hif-1alpha were derived by normalisation to
actin and are mentioned below each lane. (D) siRNA-mediated gene silencing efficiency of siNOX1 was checked by quantitative real time PCR. (E)
Change in cellular ROS content was verified after 24 h of NOX1 silencing. Data represent the mean 6 SEM of three independent experiments. **,
p#0.005. (F, G) siRNA-mediated gene silencing of NOX1 recovers HHV6-induced persistent Chlamydia. HeLa cells were transfected with 5 nM of
NOX1 and control siRNA for 48 h and then infected with Ctr alone or together with HHV6A. Infectivity was determined by immunoblotting (F) and
inclusion counting (G). Inclusion counting data represent the mean 6 SEM of three independent experiments. **, p#0.005. PI, primary infection; SI,
secondary infection. IFU, inclusion forming units. Data in figure (D), (E) and (G) represent the mean of 3 independent experiments performed on the
same day whereas the data in figure (F) represents one of the three biological replicates.
doi:10.1371/journal.pone.0047427.g004
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low but measurable in co-infected cells (Figure 6A), indicating
reduced GSR activity in virus- and co-infected cells. In line with
NADPH levels as indicators for the GSR reaction, NAC
treatment, which rescued chlamydial infectivity (Figure 5B),
reduced the increased NADPH levels in co-infected cells (Figure
S6G). Consistently, interfering with glutathione biosynthesis by
BSO treatment caused a dose-dependent increase in NADPH in
Chlamydia single infected cells comparable to the co-infected cells
(Figure S6E), which interfered with chlamydial infectivity but not
primary infection (Figure 5B).
To confirm the central role of the GSR reaction in
chlamydial persistence induced by co-infection, we interfered
with NADPH synthesis by inhibiting the pentose phosphate
pathway (PPP), the central source of NADPH. Inhibition of
glucose 6-phosphate dehydrogenase (G6PDH) by 6-aminonico-
tinamide (6-ANAM) decreased cellular NADPH content
(Figure 6A) and induced persistence of Chlamydia with all
ultra-structure hallmarks of chlamydial inclusions observed
under co-infection conditions (Figure 6B,C). To test whether
specifically targeting the host PPP causes a similar effect,
G6PDH expression was silenced by RNAi. Knockdown of
G6PDH expression (Figure S6E) caused an increase in ROS
(Figure 6D) and a partial induction of chlamydial persistence in
the absence of viral co-infection (Figure 6E, S6F).
In conclusion, the strong decrease in GSH level and elevation of
NADPH levels in virus infected cells suggested that HHV6
interferes with the GSR activity provoking an imbalance in the
detoxification of ROS and, as a consequence, the induction of
chlamydial persistence during co-infection.
Herpes Simplex Virus (HSV)-1 and Human
Cytomegalovirus (HCMV) Induce ROS-dependent
Chlamydial Persistence
To test whether other herpes viruses also provoke chlamydial
persistence by a similar mechanism as HHV6, co-infection with
HSV-1 and HCMV, members of the alpha and beta herpes virus
group, respectively, was established. Co-infection with HSV-1 and
HCMV induced loss of chlamydial infectivity and this effect could
be reverted by scavenging ROS with DTT (Figure 7A, B, C, D),
demonstrating that the mechanism described here is of broader
significance in the interaction of Chlamydia and herpes viruses.
Discussion
C. trachomatis is the most frequent obligate intracellular human
pathogenic bacterium that infects many different cell types and
causes a wide variety of infectious diseases. Here, we show that
chlamydial co-infections with HHV6, one of the most prevalent
viruses in humans worldwide, massively influence the infectivity of
the bacteria by inducing fully reversible persistence. This effect is
independent of productive virus infection and largely depends on
prolonged oxidative stress in the co-infected cells.
The amazingly strong and complete induction of chlamydial
persistence in presence of high HHV6 titers (MOI of 5–10) was
special in several aspects. Unlike as in persistence induced by
antibiotics treatment, bacteria retained DNA replication for
several days but re-entered the productive developmental cycle
nearly quantitatively as soon as the virus was removed from the
culture in line with the observations of recovery after HSV2-
mediated [6] as well as penicillin-induced persistent Chlamydia
[33,34]. It is therefore very likely that co-infection induces a
distinct persistence program in Chlamydia that not only enables the
bacteria to rapidly exit from the productive developmental cycle
but also to immediately recover once the virus is removed from the
cell. HHV6 co-infection had no effect on the infectivity of Simkania,
which unlike C. trachomatis and C. pneumoniae can also infect and
grow in amoeba [35]. It is therefore tempting to speculate that
human specific HHV6 and the human pathogenic Chlamydia co-
evolved in or compete for related niches.
Blood cells are suspected to act as a host and carrier of C.
trachomatis as well as C. pneumoniae as infectious Chlamydia have been
detected in patient blood samples [36,37]. Although HHV6 infects
both T-cells as well as macrophages, it has a productive life cycle
in T-cells but achieves latency in other cell types including
macrophages [38]. Interestingly, HHV6 can still maintain the
replicative life cycle for several days in macrophages and can also
be re-activated from latency in these cells by different factors
including phorbol ester [38]. Thus, human peripheral blood cells
are both natural targets for C. trachomatis and active HHV6
infection and thus represent prime sites for co-infection of both
these pathogens in vivo. C. trachomatis maintains a productive
infection in monocyte-derived macrophages [16] and in human
macrophages from healthy blood donors (Figure 1E). However,
macrophages co-infected with HHV6A and C. trachomatis con-
tained mostly persistent Chlamydia similarly as in epithelial and
endothelial cells. Interestingly, although the blood cell infection
procedure allowed viral and chlamydial co-infection only for one
hour, subsequent removal of extracellular virus and Chlamydia from
culture media by stringent washing did not prevent occurrence of
persistent Chlamydia infections for as long as 72 h in these cells.
This observation is in cohorts with our data from HUVEC cells.
Hence, the possibility of natural co-infections of HHV6 and C.
trachomatis is indisputable.
Figure 5. HHV6 co-infection alters cellular glutathione balance. (A) Effect of HHV6A and Chlamydia infection on cellular GSH and GSSG
content. HeLa cells were infected with Chlamydia (Ctr) and/or HHV6A for different time intervals. Total GSH and GSSG contents were measured using
commercially available kits. Data represent the mean 6 SD of three biological replicates performed on the same day. (B) Effect of glutathione
precursor NAC and inhibitor (BSO) on chlamydial infectivity. HeLa cells were infected with Ctr for 2 h before NAC together with HHV6A or BSO
without HHV6A were added at different concentrations. Infectivity assay were performed and analyzed by quantitative immunoblotting and counting
of the inclusions. Cellular GSH and GSSG content was measured in parallel sets of infected cells 24 h after addition of NAC and BSO. IFU, inclusion
forming units. *, p#0.05; **, p#0.005. (C) Exogenous supplement of DTT rescues chlamydial infectivity. HeLa cells were infected either with
Chlamydia (Ctr) or together with HHV6A. Infected cells were supplemented with DTT (1 mM). Infectivity assay were performed to check chlamydial
infectivity. The cellular GSH content was measured in parallel sets of primary infected cells 20 h after addition of DTT. PI, primary infection; SI,
secondary infection. (D) 2-AAPA, an inhibitor of glutathione reductase reduces chlamydial infectivity. 2-AAPA was added to HeLa cells at 3 different
concentrations and time points of single (Ctr) infected cells. Co-infection with HHV6A and treatment with the solvent DMSO were used controls. NI,
no infection. (E) Change in cellular ROS content was measured in HeLa after 24 h of siRNA-mediated GSR silencing. Data represent the mean 6 SEM
of three independent experiments. **, p#0.005. (F) siRNA-mediated gene silencing of GSR induces Chlamydia persistence. HeLa cells were
transfected with 5 nM of GSR siRNA for 48 h. In parallel, a control siRNA pool was also transfected. siRNA transfected cells were then infected with Ctr
for 48 h followed by Infectivity assay. Inclusion counting was carried out to check Chlamydial infectivity. Inclusion counting data represent the mean
6 SEM of three independent experiments. *, p#0.05. NI: no infection. Data in figure (D), (E) and (F) represent the mean of 3 independent experiments
performed on the same day.
doi:10.1371/journal.pone.0047427.g005
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The competition for similar niches may be a more general
phenomenon in the interaction of viruses and Chlamydia. HCMV,
HSV-1 (Figure 7) and HSV-2 [6,7,8,9] have been shown to induce
persistence in C. trachomatis co-infections with similar features as
those described here for HHV6. HSV-1 and -2 (alpha-herpesvirus)
differ in their host cell specificity from HCMV and HHV6 (beta-
herpesvirus). The viral preference for lytic growth or latency also
depends on the cell type. How these viruses despite of their
individual differences similarly affect chlamydial growth is an open
question. It has been shown that HSV2 glycoprotein D induces
chlamydial persistency [6]. We could not find sequence homology
between HSV2 glycoprotein D with any of the HHV6 glycopro-
teins. In addition, we tested the effect of HHV6 glycoprotein Q1,
Q2, B and H on chlamydial growth and could not observe any
significant effect (data not shown), suggesting the involvement of a
completely different signaling pathway capable of altering
bacterial growth and infectivity. Further, co-infections of C.
pecorum with porcine epidemic diarrhea virus (PEDV) induced
persistence in Vero cells [39,40]. Our data on the rescue of
chlamydial infectivity by applying ROS scavengers and reducing
agents to cells co-infected with HHV6A, HHV6B, HCMV and
HSV-1 indicated a similar and general mechanism driving
Chlamydia into persistence in these cells. It may be possible that
different herpes viruses have evolved additional or independent
mechanisms to regulate host cell physiology, which can interfere
with chlamydial growth.
We have used multiple approaches to show that HHV6 entry
into the host cell is essential for the development of chlamydial
persistency. Absence (Figure 2C, D) or RNAi mediated knock
down (Figure 2E, F) of HHV6A-specific receptor, CD46,
decreased HHV6A-mediated chlamydial persistency. Although
HHV6 is a lymphotropic virus that replicates in CD4+ or CD8+ T
lymphocytes, the HHV6A receptor CD46 required for virus entry
is present on all nucleated cells [41]. Our data showing that only
Figure 6. HHV6 co-infection alters cellular NADPH balance by inhibiting GSR activity. (A) Chlamydia infection depletes, HHV6 infection
increases cellular NADPH level. HeLa cells were infected with Chlamydia (Ctr) in the presence or absence of HHV6A or HHV6B. Total NADPH content of
the cells was measured after 24 h of infection. NADPH level was also measured under similar infection conditions from cells pre-treated with 5 nM 6-
ANAM for 24 h. Data represent the mean 6 SEM of three independent experiments performed on the same day. *, p#0.05 (B) 6-ANAM induces
chlamydial persistency. HeLa cells were treated with 5 nM 6-ANAM for 24 h followed by infectivity assay to measure chlamydial persistency. Inclusion
counting was used to check the chlamydial infectivity. Data represent the mean 6 SEM of three independent experiments. (C) Electron microscopy
picture of a chlamydial inclusion in HeLa cells treated with 5 mM 6-ANAM for 24 h. (D) Change in cellular ROS content was measured in HeLa cells
after 24 h of siRNA-mediated G6PDH silencing. **, p#0.005. (E) siRNA mediated silencing of G6PDH expression reduces Chlamydia infectivity. HeLa
cells were transfected with 5 nM of G6PDH siRNA for 48 h. In parallel, a control siRNA pool was also transfected. siRNA transfected cells were then
infected with Ctr for 48 h followed by Infectivity assay. Inclusion counting was carried out to check chlamydial infectivity. *, p#0.05. Data in figure (D)
and (E) represent the mean 6 SEM of three independent experiments performed on the same day.
doi:10.1371/journal.pone.0047427.g006
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uptake of the virus, but not the formation of virus particles as a
prerequisite for induction of chlamydial persistence is a key finding
since it implicates that the virus and Chlamydia can interact in any
cell, which can be infected by both pathogens. The dramatically
increased uptake of virus into Chlamydia-infected cells argues in
favor for a close interaction of both pathogens already at this
critical point of the infection process. Non-productive virus
infection, on the other side, is not a prerequisite for its interference
with chlamydial infectivity since productively HHV6-infected
primary HUVECs push Chlamydia into persistence as well. Thus, a
pre-existing chlamydial infection strongly sensitizes cells for HHV6
infection, which in turn causes the temporal exit of the bacteria
from the developmental cycle and co-existence in cells either
susceptible or insusceptible for virus production.
Production of ROS is a general mechanism of cells to defeat
viruses and bacteria [42]. We found that infection of HeLa cells
with C. trachomatis alone induces transient ROS production
confirming recently published data [26,43]. The production of
ROS has been suggested to be initially induced by the activation of
the NADPH oxidase which then is rapidly inactivated in infected
cells, possibly by the recruitment of the regulatory subunit to the
inclusion Rac1 [26]. Inhibition of the bacterial protein synthesis or
the chlamydial Type 3 Secretion System prevented the induction
of ROS, supporting the idea of an active role of Chlamydia in the
induction of ROS as well. This transient activation of ROS during
chlamydial infection may initiate signaling cascades like the
activation of caspase-1 [43] and Hif-1alpha [29], which are
beneficial for the bacterial development. But these signaling
cascades strongly activated during co-infection may also influence
the physiology of the host cell. Hif-1alpha is one of the most
important transcription factors regulating the glycolytic metabo-
lism and de novo fatty acid synthesis in tumor cells [44,45]. This
change in metabolism, also referred to as Warburg effect, is
induced by Herpes viruses like CMV and Kaposi’s sarcoma herpes
virus to support the production of viral particles [46]. The high
levels of ROS, Hif-1alpha and Mcl-1 strongly suggest that
modified signaling in co-infected cells may, in addition, support
pathologies like cancer development and neurodegeneration
[47,48].
But how could imbalanced ROS production in co-infected cells
affect the development of Chlamydia? The high structural rigidity of
chlamydial EB is caused by the highly cross-linked outer
Figure 7. HCMV and HSV-1 induce chlamydial persistence. HeLa cells were infected or co-infected with Chlamydia (Ctr) and (A,B) HSV-1 or
(C,D) HCMV. Infectivity was monitored by counting inclusion numbers after staining the chlamydial inclusions with an antibody against cHsp60 and
Cy2 labeled secondary antibody (A and C) and immunoblotting (B and D). PI, primary infection; SI, secondary infection; NI: no infection; IFU, inclusion
forming units. Data in figure (A) and (C) represent the mean 6 SEM of three independent experiments performed on the same day. *, p#0.05; **,
p#0.005. Figure (B) and (D) represent one of the three biological replicates.
doi:10.1371/journal.pone.0047427.g007
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membrane protein complex, which is brought about by the intra-
and intermolecular cysteine bonds in the cysteine-rich proteins of
the EB outer envelope, such as OmpA, OmcB, and OmcA. Early
work by the Hackstadt group has already postulated that reduction
of outer membrane protein complex proteins is a prerequisite for
chlamydial EB to RB transition [49]. Recently, GSH has been
suggested to be the natural agent responsible for the reduction of
the outer membrane proteins of C. trachomatis during EB to RB
transition [50]. We observed decreased chlamydial infectivity due
to decrease in cellular GSH during later time points of Chlamydia
infection indicating a more important role of GSH for chlamydial
infectivity. Formation of infectious EB is dependent on availability
of several cysteine-rich proteins including MOMP, CrpA, OmpA,
and OmcB [51,52], which are incorporated either in a monomeric
or cross-linked form to the outer membrane of newly formed EBs.
Disulfide bond formation is crucial for the structure and stability of
chlamydial proteins including MOMP whose disulfide bonds have
been shown to be dynamic rather than stable and adapt to
structural changes during the RB and EB transition [53].
Accumulation of NADPH together with decreased GSH during
co-infection could influence the reduction of disulfide bonds of
these proteins and thus may affect RB to EB re-differentiation.
The conversion of GSSG to GSH involves NADPH and the key
enzyme GSR. Consistent with increased consumption of GSH by
Chlamydia, single infected cells were virtually depleted of NADPH
(Figure 6A) and the GSH levels, which were reduced at early time
points, increased for the period of the infection cycle when EB
transform to RB (8–20 h; Figure 5A). Furthermore, only reducing
agents, which increased the GSH level, also rescued chlamydial
infectivity in co-infected cells. And finally, interfering with GSH
production either indirectly by depleting NADPH or directly by
inhibiting GSH synthesis induced chlamydial persistence reminis-
cent to the co-infection situation. We therefore hypothesize that
HHV6 co-infection directly interferes with the initial conversion of
RB to EB by generating and maintaining an imbalanced GSH/
GSSG ratio. This model would also explain why addition of
HHV6 virus particles after RB to EB conversion at around 24 h
post chlamydial infection did not affect chlamydial persistence
(Figure 1D), since GSH levels are similar around this time point in
single and co-infected cells (Figure 5A). Bactericidal antibiotics
including Penicillin G decreases NADPH level in cell either by
modulating G6PDH function [54] or by stimulation of oxidation
of NADH leading to depletion of reducing equivalents with
concomitant increase in hydrogen radical mediated damage [55].
Decreased NADPH level could alter the cellular GSH balance,
which can be a possible cause for penicillin-induced chlamydial
persistency. These observations support our results and points
towards common machinery that can be crucial for the successful
transition of chlamydial RB to EB development.
Decrease in GSH level and concomitant elevation of NADPH
levels in the virus single infected cells strongly suggests that HHV6
infection interferes with GSR activity and thus causes an
imbalance in the detoxification of ROS. Our findings of a role
of ROS and GSH levels in the competition between virus and
Chlamydia provide a first insight into the mechanism by which
chlamydial persistence is induced in these co-infections. We are
just beginning to understand how the co-evolution of one of the
most prevalent human pathogenic bacteria and viruses has
affected their survival and replication strategies, but also their
infective properties while occupying similar niches inside the cell.
The Chlamydia - HHV6 interaction may thus provide a paradigm
for a so far unrecognized close interaction of obligate intracellular
bacteria and viruses.
Materials and Methods
Cell Culture and Virus Stock Preparation
HSB2 cells and HHV6A viral particles were kindly provided by
Prof. Harald zur Hausen [56]. HUVEC cells were purchased from
ENZO life sciences, Germany. Molt3 cells, CiHHV6A cell lines
and HHV6B (Z29) viral particles were kindly provided by the
HHV6 foundation, USA. HeLa, HSB2, Molt3 and CiHHV6A
cells were grown in RPMI 1640 media and 5% fetal bovine serum
(FBS) at 37uC and 5% CO2. Primary HUVEC were grown in
endothelial cell growth medium (Promo Cell) with added growth
additives (C-39215, Promo Cell). HHV6A and HHV6B were
infected and propagated in HSB2 and Molt3 cells respectively
without any antibiotics (see Materials and Methods S1).
PBMC Isolation
Fresh PBMCs were first separated from whole blood using
Histopaq1077 solution (Sigma, St. Louis, MO, USA) using
manufacturer’s instructions. Briefly, freshly collected blood was
diluted 2 times with PBS and layered carefully onto 1 volume of
Histopaq1077 solution in a falcon tube without mixing the
solutions. PBMCs were collected after centrifugation at 6006g for
30 min at room temperature without applying brake. Cells were
washed 3 times with 25 volumes of PBS and were kept in RPMI
1640 media with 5% fetal bovine serum (FBS) and 5 mg/ml of
phytohemagglutinin (PHA) (Sigma, USA) at 37uC and 5% CO2.
PHA stimulation was used to induce HHV6 infection in PBMCs
[38]. Isolated PBMCs were cultured on a plastic culture disc
(NUNC, USA) for 48 h to separate monocytes from rest of the
blood cells. Separated adherent monocytes were further cultured
for 5–7 days in presence of 50 ng/ml macrophage colony
stimulating factor (M-CSF) (Sigma, USA) to allow complete
differentiation into macrophages. Both the adherent macrophage
fraction and the PBMC fractions were infected with Chlymdia
and/or HHV6 separately.
Chlamydia Infection and Co-infection
The preparation of chlamydial stocks has been described
previously [57]. One day before infection, epithelial cells were
seeded in 6 or 12-well plates (Greiner) to reach sub-confluency.
Cell media was replaced by fresh medium (RPMI 1640, 5% FBS)
containing Chlamydia or were left uninfected (control). Cells were
incubated at 35uC and 5% CO2 for 2.5 h before the medium was
replaced by fresh cell culture medium for further incubation.
HSB2 cells, CiHHV6A cells and PBMCs (both monocyte
derived macrophages and leukocytes) were infected with C.
trachomatis at an MOI of 2 either in an Eppendorf tube or on a
culture plate and were centrifuged for 1 h at 37uC at 1200g
(modified from Manor and Sarov, 1986 [16]). Cells were washed 3
times with PBS and were grown in fresh RPMI 1640 media with
5% FBS.
For all co-infection experiments, both HHV6 and Chlamydia
were added to the cells at the same time unless otherwise
mentioned. For some of the experiments, viral particles were
inactivated by UV exposure (26106 mJ) for 2 h (UV.HHV6A and
UV.HHV6B) prior to co-infection and were added simultaneously
with Chlamydia.
Infectivity Assay
48 h p.i., cells (infected or uninfected controls) were washed
once with PBS and lysed by a freeze-thaw cycle followed by
pipetting the cells repeatedly. 1:100 diluted cell lysates containing
EB were transferred to uninfected cells that had been seeded into
24 wells on glass slides the day before, incubated for 24 h at 35uC
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and fixed in 4% formaldehyde (PFA). After permeabilization with
PBS +0.2% Triton X-100 for 20 min at RT and blocking with
PBS +10% FBS for 1 h at RT, cells were stained with an antibody
against chlamydial Hsp60 (cHsp60) in PBS +2% FBS at RT for
1 h. Cells were washed with PBS thrice and incubated with a Cy2-
labeled secondary antibody and Hoechst (or DAPI) in PBS +2%
FBS for 1 h in the dark at RT. Slides were washed twice in PBS,
once in distilled water to remove PBS and were mounted on
Mowiol (Carl Roth). The number of inclusions was determined by
counting ten random fields using epifluorescence microscope
(Leica) at 40x magnification. For confocal laser scanning
microscopy, samples were stained with Draq5 instead of
Hoechst/Dapi and analyzed using a Leica TCS SPE equipped
with 488, 532, and 635 nm solid-state lasers for excitation. Images
were taken using appropriate excitation and emission filters for the
fluorescence dyes. Overlay images of the single channels were
obtained using ImageJ. Infectivity was also determined by
quantifying chlamydial Hsp60 (cHsp60) by immunoblotting using
antibodies against Chlamydia specific Hsp60. The values were
normalized to actin after signal quantification using densitometric
analysis and ImageJ software. Number of inclusion forming units
(IFU) per ml was determined by analyzing five random fields in an
epifluorescence microscope with 400-fold magnification.
Immunoblotting
Cell lysates were resolved by 10% sodium dodecyl sulfate (SDS)-
poly- acrylamide gel electrophoresis. Proteins were transferred to
polyvinylidene difluoride membranes (Millipore) and blocked with
10% skimmed milk. The membranes were then probed with
respective primary antibodies and subsequently with HRP-
conjugated secondary antibodies. Proteins were detected with
peroxidase-coupled secondary antibody using the ECL system
(Amersham). Antisera and antibodies used in this study are listed
under materials and methods S1.
Cell Transfections and RNA Interference
Transfections were performed using Lipofectamine 2000
(Invitrogen) as per manufacturer’s protocol. To silence CD46,
G6PDH, GSR, Nox1 gene expression by RNA interference,
16105 cells per well were seeded into a 12-well plate on the day of
transfection. Freshly seeded HeLa cells were transfected with
160 nM siRNAs using RNAiFect transfection reagent (QIAGEN,
Valencia, CA) according to the manufacturer’s instructions.
Efficiency of gene silencing was generally validated either by
western blot analysis or qPCR at 72 h post-transfection. All the
siRNAs (ON-TARGETplus smartpool) including a control siRNA
pool were purchased from Dharmacon, Thermo Fisher Scientific.
NADPH Measurement
Total cellular NADPH level measured by NADP/NADPH
Assay Kit (Abcam) using manufacturers protocol. To detect
NADPH only, NADP was decomposed before the final reaction by
heating the samples at 60uC for 30 min in a heating block.
Bioluminescence was measured on an ELISA reader (TECAN
Infinite M200) at 450 nM.
Thiol Fluorescence Assay for GSH Measurement
Infected cells were washed three times with warm PBS. Cells
were lysed by three freeze–thaw cycles at -80uC. Thiol-reactive
Alexa Fluor 488 C5 maleimide (Invitrogen, USA) was added to the
cell lysate at a dilution of 1:5000 (stock 10 mg/ml). After an
incubation of 5–10 min, the GSH content in the cell lysates were
measured by an ELISA plate reader (TECAN Infinite M200)
using an excitation filter of 480 nm and emission filter of 530 nm.
DCF Assay for Cellular ROS Activity Study
Total cellular ROS activity was measured using OxiSelectTM
Intracellular ROS Assay Kit (Cell Biolabs Inc., USA) according to
the manufacturer’s protocol and an ELISA plate reader (TECAN
Infinite M200) with an excitation filter of 480 nm and emission
filter of 530 nm.
Statistical Analysis
Statistical significance (p values) of acquired data was calculated
using two-sided Student’s t-test.
Supporting Information
Figure S1 (A,B) HeLa cells were co-infected with HHV6A and
6B and C. pneumoniae (A) or HHV6A and S. negevensis (B) and
infectivity was determined after 3 or 4 days post infection,
respectively. Cell supernatants were collected 72 h p.i. and were
added to freshly growing HeLa cells. At 24 h p.i., cells were fixed
and stained for bacterial Hsp60 protein with an antibody against
cHsp60 and Cy2-coupled secondary antibody. Inclusion numbers
were counted under a fluorescence microscope against the nuclear
DAPI staining. IFU, inclusion forming units. Data represent the
mean 6 SEM of two independent experiments. (C) Early co-
infection with HHV6 is necessary for inducing chlamydial
persistence. HeLa cells were infected with Chlamydia for 2 h prior
to the addition of viral particles for different time points as
indicated. In a parallel infection set up, HHV6A was added to
Chlamydia-infected cells after 2 h, but subsequently HHV6 was
removed from the infection media at the indicated time points.
Infectivity assays were performed as described in Materials and
Methods and immunoblotting was done to check the bacterial
Hsp60 protein (cHsp60) expression. PI, primary infection; SI,
secondary infection; IFU, inclusion forming units.
(TIF)
Figure S2 (A) Interferon response is unchanged in single and co-
infected cells. Heatmap analysis of microarray data showing
differentially expressed interferon genes in HeLa cells under
different infection conditions as compared to non-infected cells.
Total RNA preparations from non-infected as well as HeLa cells
infected with C. trachomatis (Ctr) and/or HHV6B were analyzed.
White or red colors indicate differentially up- or down-regulated
genes, respectively according to their log2 fold change values.
IFNG, Interferon gamma; IFNE, Interferon epsilon; IFNB1,
Interferon betta 1; IFNK, Interferon kappa; IL28A, Interleukin
28A; IFNA8, Interferon alpha 8; IFNA4, Interferon alpha 4;
IFNA10, Interferon alpha 10; IFNA16, Interferon alpha 16;
IFNA2, Interferon alpha 2; MX1, myxovirus resistance 1; IL18,
Interleukin 18; IFNA6, Interferon alpha 6; IL29, Interleukin 29;
IL6, Interleukin 6; IL28B, Interleukin 28B; IFNA21, Interferon
alpha 21. (B) High HHV6 U94 transcription together with the
lack of other viral gene transcription demonstrates viral latency.
Viral latency was characterized by amplification of HHV6 U94
and U22 transcripts. High transcription of U94 together with
absence of U22 transcripts validated that the HHV6 genome was
maintained in a latent state. (C) HHV6 glycoproteins are
expressed in infected HUVEC cells. HUVEC cells were infected
with HHV6A for 72 h and gp116 and p41 were detected by
immunostaining using antibodies against the respective proteins
and Cy3-coupled secondary antibodies. Draq5 staining was used
to stain cellular DNA. Samples were viewed under a confocal laser
microscopy. Scale bar, 10 mm.
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(TIF)
Figure S3 Co-infection of HHV6A and C. trachomatis (Ctr) favors
viral survival and entry. (A) Chlamydial replication is down
regulated by HHV6. HeLa cells were infected with C. trachomatis
and/or HHV6A for different time intervals and DNA was
extracted from these cells. Chlamydial DNA was quantified by
qPCR, using a primer set against chlamydial LcrH/SycD.
Relative viral and Ctr DNA quantity were derived by normalizing
the values against 5S rDNA as internal control. In all the graphs,
relative values are normalized to 1. Data represent the mean 6
SEM of three independent experiments. (B) Penicillin G and
Doxycyclin have no effect on single infection with HHV6A. HSB2
cells were infected with HHV6A in absence of any antibiotics. In
parallel 2 other sets of HSB2 cells were infected with HHV6A
either in presence of 10 U/ml of Penicillin G or 100 ng/ml of
Doxycyclin for different times. DNA was extracted and used for
qPCR with primers against viral U94 ORF. Relative quantity of
U94 level was derived by normalizing against 5s rDNA as internal
control. Relative viral DNA values are normalized to 1. Data
represent the mean 6 SEM of three independent experiments.
hpi, hours post infection; dpi, days post infection. (C) HHV6B
gene transcription is induced during co-infection with Ctr. HeLa
cells were either infected with HHV6A or Ctr alone or co-infected
together for 24 h. Total RNA was extracted, reverse transcribed
and used for semi-quantitative RT-PCR using primers against
viral U22, U42, U79, U91 and U94 ORFs. Amplified products
were run on a 2% agarose gel. GAPDH amplification was used as
an internal control. Fold change values were derived by dividing
respective band intensity with GAPDH band intensity and are
mentioned below respective bands. RT, reverse transcriptase; M,
marker.
(TIF)
Figure S4 (A) Co-infection of HHV6 and Ctr down regulates
host cell mitochondrial membrane potential and induces cyto-
chrome c release. HeLa cells were infected with Ctr and/or
HHV6A. As a control, persistence was induced with penicillin G
(PenG). Mitochondrial membrane potential was measured in
HeLa cells by staining with Mito Tracker (red). Co-staining was
done for cytochrome c (green) with using antibody against human
cytochrome c and Cy2-coupled secondary antibody (green). Co-
localization of mitochondria and cytochrome c was studied under
a confocal microscope. (B) HHV-6A and -6B induces Hif-1alpha.
HeLa cells were infected with Ctr and/or HHV-6A for different
time intervals either in the presence (+DTT) or absence (-DTT) of
1 mM DTT. Chlamydia (cHSP60), Hif-1a and Mcl-1 expression
was detected by immunoblotting. Actin was used as a loading
control. Fold change values of Hif-1alpha and Mcl-1 was derived
by dividing respective values with Actin and are mentioned below
each lane.
(TIF)
Figure S5 Hif-1a expression is induced during co-infection with
HHV6. HeLa cells were infected with Ctr and/or HHV6A for
different times. Cells were fixed and stained for Hif-1alpha using
an antibody against human Hif-1alpha and Cy3-coupled second-
ary antibody (Red). Host cell DNA was stained with DAPI (blue).
Fluorescence microscopy was used to visualize the localization of
Hif-1a.
(TIF)
Figure S6 (A) DTT has no negative effect on HHV6 survival
inside the host cell during co-infection. HeLa cells were infected
either with Ctr or together with HHV6A. Infected cells were
supplemented with DTT (1 mM). Total RNA was extracted after
24 h of infection and viral U94 transcript level was quantitated
using primers against HHV6A U94. Relative U94 transcript level
was derived by normalizing the values against 5s rRNA internal
control. Relative U94 values are normalized to 1. Data represent
the mean 6 SEM of three independent experiments. (B & C)
SOD prevents HHV6-mediated chlamydial persistence. HeLa
cells were either first treated with SOD (22 h p.i.) or directly
infected either with Chlamydia (Ctr) or together with HHV6A.
SOD at different concentrations was added to cells at 3 different
time points of infection. Infectivity assay was performed as
described in material and methods to check chlamydial infectivity.
Immunoblotting (B) was done and inclusion numbers were
counted (C) to check chlamydial infectivity. IFU, inclusion forming
units. Immunoblot (B) represents one of the three biological
replicates. IFU/ml data (C) represent the mean 6 SEM of three
independent experiments. (D) Total cellular GSH and GSSG
level was measured in HeLa cells after 24 hrs of 2-AAPA
treatment. Data represent the mean 6 SEM of three independent
experiments. (E) siRNA mediated gene silencing of G6PDH, GSR
was verified by immunoblotting. Data represents one of the three
biological replicates. (F) siRNA mediated gene silencing of
G6PDH, GSR decreases Chlamydial infectivity. HeLa cells were
transfected with 5 nM of G6PDH, GSR siRNAs for 48 hrs. In
parallel, a control siRNA pool was also transfected. siRNA
transfected cells were then infected with Ctr or together with
HHV6A. Infectivity assay and immunoblotting was carried out to
check Chlamydial infectivity. siRNA-mediated gene silencing
efficiency was checked by using antibodies against G6PDH and
GSR. Actin was detected as a loading control. Data represents one
of the three biological replicates. (G) N-acetyl-l-cysteine (NAC)
and buthionine sulfoximine (BSO) changes cellular NADPH level.
HeLa cells were infected with C. trachomatis (Ctr) alone or together
with HHV6A. Infected cells were treated with NAC or BSO at 3
different concentrations for 24 h. Total NADPH content of the
cells was measured after 24 h of infection. Data presented here are
the mean of 3 independent experiments. PI, primary infection; SI,
secondary infection; NI: no infection.
(TIF)
Table S1 Primers used for semi-quantitative RT-PCR and
qRT-PCR.
(DOC)
Materials and Methods S1.
(DOCX)
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